JP2003516148A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003516148A5 JP2003516148A5 JP2001544321A JP2001544321A JP2003516148A5 JP 2003516148 A5 JP2003516148 A5 JP 2003516148A5 JP 2001544321 A JP2001544321 A JP 2001544321A JP 2001544321 A JP2001544321 A JP 2001544321A JP 2003516148 A5 JP2003516148 A5 JP 2003516148A5
- Authority
- JP
- Japan
- Prior art keywords
- piv
- antigenome
- virus
- genome
- chimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17019599P | 1999-12-10 | 1999-12-10 | |
| US09/459,062 US7250171B1 (en) | 1997-05-23 | 1999-12-10 | Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein |
| US09/459,062 | 1999-12-10 | ||
| US09/458,813 | 1999-12-10 | ||
| US60/170,195 | 1999-12-10 | ||
| US09/458,813 US7314631B1 (en) | 1997-05-23 | 1999-12-10 | Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) |
| PCT/US2000/033293 WO2001042445A2 (en) | 1999-12-10 | 2000-12-08 | USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003516148A JP2003516148A (ja) | 2003-05-13 |
| JP2003516148A5 true JP2003516148A5 (https=) | 2008-02-07 |
| JP4795597B2 JP4795597B2 (ja) | 2011-10-19 |
Family
ID=27389780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001544321A Expired - Fee Related JP4795597B2 (ja) | 1999-12-10 | 2000-12-08 | パラインフルエンザウィルス（ｐｉｖ）及びヒトの病原体により引き起こされる感染及び疾病を保護するためへの組換えｐｉｖのベクターとしての使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1179054A2 (https=) |
| JP (1) | JP4795597B2 (https=) |
| CN (2) | CN102766605A (https=) |
| AU (1) | AU785148B2 (https=) |
| CA (1) | CA2362685A1 (https=) |
| IL (1) | IL144831A0 (https=) |
| MX (1) | MXPA01008108A (https=) |
| WO (1) | WO2001042445A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6764685B1 (en) | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| CA2435180C (en) | 2001-01-19 | 2019-04-09 | Vironovative B.V. | A virus causing respiratory tract illness in susceptible mammals |
| US8715922B2 (en) | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| ATE509097T1 (de) | 2001-11-21 | 2011-05-15 | Us Health | Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna |
| CN1646684B (zh) | 2002-02-21 | 2010-10-06 | 免疫医疗疫苗公司 | 重组副流感病毒表达系统以及包含源自间质肺病毒的异种抗原的疫苗 |
| EP1539944A4 (en) | 2002-07-01 | 2005-12-28 | Univ Wayne State | METHOD AND COMPOSITIONS FOR IDENTIFYING ANTIBIOTICS HARMFUL TO ANTIBIOTIC RESISTANCE |
| WO2004027037A2 (en) | 2002-09-18 | 2004-04-01 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS |
| JP2007524372A (ja) | 2003-02-28 | 2007-08-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 組換えヒトメタニューモウイルスおよびその使用 |
| CN101410519B (zh) | 2003-04-25 | 2013-04-24 | 免疫医疗有限责任公司 | 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法 |
| CN1871355B (zh) | 2003-06-09 | 2011-12-14 | 惠氏 | 从cDNA中回收非节段性负链RNA病毒的改进方法 |
| DE102005006388A1 (de) | 2005-02-11 | 2006-08-24 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Replikationsdefiziente RNA-Viren als Impfstoffe |
| AU2006243923B2 (en) | 2005-05-11 | 2011-09-22 | Wayne State University | Novel targets for the identification of antibiotics that are not susceptible to antibiotic resistance |
| US8293517B2 (en) | 2005-05-11 | 2012-10-23 | Wayne State University | Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in Pseudomonas aeruginosa |
| JP4905649B2 (ja) * | 2006-03-08 | 2012-03-28 | 国立大学法人 長崎大学 | 魚用ワクチン、その製造方法、および魚類感染症の予防方法 |
| JP4892296B2 (ja) | 2006-08-24 | 2012-03-07 | 川崎製薬株式会社 | 魚類のエドワジェラ症及び連鎖球菌症用ワクチン |
| US8362203B2 (en) | 2009-02-10 | 2013-01-29 | Wayne State University | Non-natural peptides as models for the development of antibiotics |
| EP3101122B1 (en) | 2009-08-24 | 2023-06-14 | Baylor College of Medicine | Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses |
| ES2728248T3 (es) * | 2012-01-24 | 2019-10-23 | Univ Georgia | Vacunas basadas en el virus paragripal 5 |
| PT2812431T (pt) | 2012-02-09 | 2019-10-18 | Baylor College Medicine | Pepmixes para gerar ctls multivirais com larga especifidade |
| CN103773803A (zh) * | 2014-01-23 | 2014-05-07 | 中国农业科学院特产研究所 | 表达猪o型口蹄疫病毒vp1蛋白的重组牛副流感病毒载体 |
| CN110996998A (zh) * | 2017-05-29 | 2020-04-10 | 美利坚合众国- 由健康及人类服务部部长代表 | 表达rsv g的重组嵌合牛/人副流感病毒3及其用途 |
| SG11202012349QA (en) * | 2018-06-27 | 2021-01-28 | Medicago Inc | Influenza virus hemagglutinin mutants |
| EP3844758A1 (en) * | 2018-08-28 | 2021-07-07 | Koninklijke Philips N.V. | Method for assessing genome alignment basis |
| IL286629B2 (en) * | 2019-03-25 | 2024-10-01 | Baylor College Medicine | Multi-respiratory virus antigen-specific t cells and methods of making and using the same therapeutically |
| CN113462656B (zh) * | 2021-03-24 | 2022-09-30 | 兰州生物制品研究所有限责任公司 | 一种人三型副流感病毒冷适应温度敏感株及其应用 |
| CN113999292B (zh) * | 2021-10-27 | 2023-05-26 | 中国农业大学 | 靶向呼吸道病毒属病毒的多肽抑制剂 |
| CA3257090A1 (en) | 2022-05-25 | 2023-11-30 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | REDUCED VECTOR ANTIGENICITY VACCINE |
| TW202535439A (zh) | 2023-11-17 | 2025-09-16 | 美商賽諾菲巴斯德公司 | 海藻糖疫苗調配物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100702523B1 (ko) * | 1997-05-23 | 2007-04-04 | 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 | 클로닝된 뉴클레오타이드 서열로부터 약독화된파라인플루엔자 바이러스를 제조하는 방법 |
| CN101392239A (zh) * | 1999-07-09 | 2009-03-25 | 美国政府健康及人类服务部 | 减毒的人-牛嵌合副流感病毒(piv)疫苗 |
-
2000
- 2000-12-08 AU AU20731/01A patent/AU785148B2/en not_active Ceased
- 2000-12-08 CN CN201010556188XA patent/CN102766605A/zh active Pending
- 2000-12-08 CN CN00805939A patent/CN1347453A/zh active Pending
- 2000-12-08 CA CA002362685A patent/CA2362685A1/en not_active Abandoned
- 2000-12-08 JP JP2001544321A patent/JP4795597B2/ja not_active Expired - Fee Related
- 2000-12-08 WO PCT/US2000/033293 patent/WO2001042445A2/en not_active Ceased
- 2000-12-08 IL IL14483100A patent/IL144831A0/xx unknown
- 2000-12-08 MX MXPA01008108A patent/MXPA01008108A/es not_active Application Discontinuation
- 2000-12-08 EP EP00984052A patent/EP1179054A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003516148A5 (https=) | ||
| Wang et al. | Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases | |
| Baron et al. | Rescue of rinderpest virus from cloned cDNA | |
| Jin et al. | Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo | |
| Durbin et al. | Recovery of infectious human parainfluenza virus type 3 from cDNA | |
| JP4795597B2 (ja) | パラインフルエンザウィルス（ｐｉｖ）及びヒトの病原体により引き起こされる感染及び疾病を保護するためへの組換えｐｉｖのベクターとしての使用 | |
| US11028409B2 (en) | Replication-deficient RNA viruses as vaccines | |
| Radecke et al. | Reverse genetics meets the nonsegmented negative-strand RNA viruses | |
| KR100905450B1 (ko) | 약독화된 인간-소 키메릭 호흡기 신시티움 바이러스백신의 제조 방법 | |
| KR101020532B1 (ko) | ｃＤＮＡ로부터의 비분절 네가티브 쇄 ＲＮＡ 바이러스의 회수를 위한 개선된 방법 | |
| JP2007097600A (ja) | クローン化されたヌクレオチド配列からの感染性ＲＳウイルス（ｒｅｓｐｉｒａｔｏｒｙｓｙｎｃｙｔｉａｌｖｉｒｕｓ）の生産 | |
| JP2003504064A5 (https=) | ||
| EP1194564B1 (en) | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines | |
| EP1629004B1 (en) | Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens | |
| Skiadopoulos et al. | Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes | |
| US7250171B1 (en) | Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein | |
| CN105378090A (zh) | 呼吸道合胞病毒半活疫苗 | |
| WO2012085936A2 (en) | Recombinant respiratory syncytial virus plasmids and vaccines | |
| JP2004515218A5 (https=) | ||
| US7201907B1 (en) | Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines | |
| US7314631B1 (en) | Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) | |
| JP2008537683A5 (https=) | ||
| US20060099226A1 (en) | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines | |
| WO2001092548A2 (en) | Vaccine and gene therapy vector and methods of use thereof | |
| EP2152863B1 (en) | Human parainfluenza viruses having separated p and c genes |